Finance

Beta
Lists
CAPLIPOINT:NSE
Caplin Point Laboratories Ltd
₹1,987.70
-0.56%
(-11.20) 1D
Jun 2, 11:01:42 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CAPLIPOINT...
Open
₹2,000.00
High
₹2,007.80
Low
₹1,981.00
Mkt. cap
151.14B
Avg. vol.
178.62K
Volume
19.14K
Dividend
0.35%
Quarterly dividend
₹1.75
Ex-dividend date
May 29, 2026
P/E ratio
23.63
52-wk high
₹2,395.00
52-wk low
₹1,500.30
EPS
₹84.11
Shares outstanding
75.60M
No. of employees
4K
Open
₹2,000.00
High
₹2,007.80
Low
₹1,981.00
Mkt. cap
151.14B
Avg. vol.
178.62K
Volume
19.14K
Dividend
0.35%
Quarterly dividend
₹1.75
Ex-dividend date
May 29, 2026
P/E ratio
23.63
52-wk high
₹2,395.00
52-wk low
₹1,500.30
EPS
₹84.11
Shares outstanding
75.60M
No. of employees
4K
News stories
From sources across the web
About Caplin Point Laboratories Ltd
CEO-
Employees3.97K
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitecaplinpoint.net
Last report
May 14, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
6.00B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.10B
5.34B
5.43B
6.00B
Cost of goods sold
1.95B
2.10B
2.15B
2.45B
Cost of revenue
1.95B
2.10B
2.15B
2.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
431.60M
472.30M
497.80M
526.20M
Operating expense
1.54B
1.53B
1.57B
1.70B
Total operating expenses
3.49B
3.63B
3.72B
4.15B
Operating income
1.61B
1.71B
1.70B
1.85B
Other non operating income
231.40M
303.70M
336.80M
283.60M
EBT including unusual items
1.84B
2.01B
2.04B
2.13B
EBT excluding unusual items
1.84B
2.01B
2.04B
2.13B
Income tax expense
337.00M
407.70M
380.30M
405.60M
Effective tax rate
18.27%
20.28%
18.65%
19.00%
Other operating expenses
940.60M
873.40M
881.60M
983.00M
Net income
1.53B
1.54B
1.64B
1.70B
Net profit margin
29.95%
28.92%
30.19%
28.34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.80M
-1.60M
-1.80M
-3.60M
Net interest expenses
-1.80M
-1.60M
-1.80M
-3.60M
Depreciation and amortization charges
162.90M
184.00M
192.80M
188.00M
EBITDA
1.78B
1.88B
1.86B
2.04B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer